NEPH Utang jangka cendhak perusahaan Nephros Corporation

The short-term debt history of Nephros, Inc. (NEPH) demonstrates stable solvency, while 0.00 reflects the latest level of the metric. The growth in Nephros, Inc. (NEPH) market share is based on the organic expansion of its hospital supply network. High FDA barriers and unique membrane patents protect the niche from new entrants. Simultaneously, the company is adapting the logistics of medical filters to overcome geopolitical distribution challenges.

This indicator is critical for liquidity stress testing and stock selection, as it allows for the assessment of short-term default risk. The dynamics of current liabilities for Nephros, Inc. (NEPH) reflect the total debt maturing within one year, which directly correlates with R&D expenditures and the commercial launch of innovative water filtration systems for medical facilities.